Skip to main content
Advertisement
  • Neurology.org
  • Journals
    • Neurology
    • Clinical Practice
    • Genetics
    • Neuroimmunology & Neuroinflammation
    • Education
  • Online Sections
    • Neurology Video Journal Club
    • Inclusion, Diversity, Equity, Anti-racism, & Social Justice (IDEAS)
    • Innovations in Care Delivery
    • Practice Buzz
    • Practice Current
    • Residents & Fellows
    • Without Borders
  • Collections
    • COVID-19
    • Disputes & Debates
    • Health Disparities
    • Infographics
    • Null Hypothesis
    • Patient Pages
    • Topics A-Z
    • Translations
  • Podcast
  • CME
  • About
    • About the Journals
    • Contact Us
    • Editorial Board
  • Authors
    • Submit a Manuscript
    • Author Center

Advanced Search

Main menu

  • Neurology.org
  • Journals
    • Neurology
    • Clinical Practice
    • Genetics
    • Neuroimmunology & Neuroinflammation
    • Education
  • Online Sections
    • Neurology Video Journal Club
    • Inclusion, Diversity, Equity, Anti-racism, & Social Justice (IDEAS)
    • Innovations in Care Delivery
    • Practice Buzz
    • Practice Current
    • Residents & Fellows
    • Without Borders
  • Collections
    • COVID-19
    • Disputes & Debates
    • Health Disparities
    • Infographics
    • Null Hypothesis
    • Patient Pages
    • Topics A-Z
    • Translations
  • Podcast
  • CME
  • About
    • About the Journals
    • Contact Us
    • Editorial Board
  • Authors
    • Submit a Manuscript
    • Author Center
  • Home
  • Latest Articles
  • Current Issue
  • Past Issues
  • Residents & Fellows

User menu

  • Subscribe
  • My Alerts
  • Log in

Search

  • Advanced search
Neurology
Home
The most widely read and highly cited peer-reviewed neurology journal
  • Subscribe
  • My Alerts
  • Log in
Site Logo
  • Home
  • Latest Articles
  • Current Issue
  • Past Issues
  • Residents & Fellows

Share

September 01, 2015; 85 (9) Special Article

Development of the Standards of Reporting of Neurological Disorders (STROND) checklist

A guideline for the reporting of incidence and prevalence studies in neuroepidemiology

Derrick A. Bennett, Carol Brayne, Valery L. Feigin, Suzanne Barker-Collo, Michael Brainin, Daniel Davis, Valentina Gallo, Nathalie Jetté, André Karch, John F. Kurtzke, Pablo M. Lavados, Giancarlo Logroscino, Gabriele Nagel, Pierre-Marie Preux, Peter M. Rothwell, Lawrence W. Svenson
First published July 10, 2015, DOI: https://doi.org/10.1212/WNL.0000000000001866
Derrick A. Bennett
From the Nuffield Department of Population Health (D.A.B.) and Stroke Prevention Research Unit (P.M.R.), University of Oxford; Department of Public Health and Primary Care (C.B.), University of Cambridge, UK; National Institute for Stroke and Applied Neurosciences (V.L.F.), AUT University, Auckland; Department of Psychology (S.B.-C.), University of Auckland, New Zealand; Department for Clinical Medicine and Preventive Medicine (M.B.), Danube-University, Krems, Austria; Faculty of Population Health Sciences (D.D.), University College London; Centre of Primary Care and Public Health (V.G.), Blizard Institute, Queen Mary, University of London, UK; Department of Clinical Neurosciences and Hotchkiss Brain Institute (N.J.), Department of Community Health Sciences and O'Brien Institute for Public Health, University of Calgary, Canada; Research Group Epidemiological and Statistical Methods (A.K.), Helmholtz Centre for Infection Research, Braunschweig, Germany; Georgetown University (J.F.K.), Washington, DC; Vascular Neurology and Stroke Unit (P.M.L.), Neurology Service, Department of Medicine, Clínica Alemana de Santiago, Universidad del Desarrollo and Department of Neurological Sciences, Universidad de Chile, Institute of Neurosurgery, Santiago; Neurodegenerative Diseases Unit (G.L.), Department of Basic Medicine, Neurosciences and Sense Organs, University Aldo Moro, Bari; Department of Clinical Research in Neurology presso Fondazione Card Panico (G.L.), Tricase (LE), University Aldo Moro, Bari, Italy; Institute of Epidemiology and Medical Biometry (G.N.), University of Ulm, Germany; Institute of Tropical Neurology (P.-M.P.), University of Limoges, France; and School of Public Health (L.W.S.), University of Alberta, Edmonton, Canada.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Carol Brayne
From the Nuffield Department of Population Health (D.A.B.) and Stroke Prevention Research Unit (P.M.R.), University of Oxford; Department of Public Health and Primary Care (C.B.), University of Cambridge, UK; National Institute for Stroke and Applied Neurosciences (V.L.F.), AUT University, Auckland; Department of Psychology (S.B.-C.), University of Auckland, New Zealand; Department for Clinical Medicine and Preventive Medicine (M.B.), Danube-University, Krems, Austria; Faculty of Population Health Sciences (D.D.), University College London; Centre of Primary Care and Public Health (V.G.), Blizard Institute, Queen Mary, University of London, UK; Department of Clinical Neurosciences and Hotchkiss Brain Institute (N.J.), Department of Community Health Sciences and O'Brien Institute for Public Health, University of Calgary, Canada; Research Group Epidemiological and Statistical Methods (A.K.), Helmholtz Centre for Infection Research, Braunschweig, Germany; Georgetown University (J.F.K.), Washington, DC; Vascular Neurology and Stroke Unit (P.M.L.), Neurology Service, Department of Medicine, Clínica Alemana de Santiago, Universidad del Desarrollo and Department of Neurological Sciences, Universidad de Chile, Institute of Neurosurgery, Santiago; Neurodegenerative Diseases Unit (G.L.), Department of Basic Medicine, Neurosciences and Sense Organs, University Aldo Moro, Bari; Department of Clinical Research in Neurology presso Fondazione Card Panico (G.L.), Tricase (LE), University Aldo Moro, Bari, Italy; Institute of Epidemiology and Medical Biometry (G.N.), University of Ulm, Germany; Institute of Tropical Neurology (P.-M.P.), University of Limoges, France; and School of Public Health (L.W.S.), University of Alberta, Edmonton, Canada.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Valery L. Feigin
From the Nuffield Department of Population Health (D.A.B.) and Stroke Prevention Research Unit (P.M.R.), University of Oxford; Department of Public Health and Primary Care (C.B.), University of Cambridge, UK; National Institute for Stroke and Applied Neurosciences (V.L.F.), AUT University, Auckland; Department of Psychology (S.B.-C.), University of Auckland, New Zealand; Department for Clinical Medicine and Preventive Medicine (M.B.), Danube-University, Krems, Austria; Faculty of Population Health Sciences (D.D.), University College London; Centre of Primary Care and Public Health (V.G.), Blizard Institute, Queen Mary, University of London, UK; Department of Clinical Neurosciences and Hotchkiss Brain Institute (N.J.), Department of Community Health Sciences and O'Brien Institute for Public Health, University of Calgary, Canada; Research Group Epidemiological and Statistical Methods (A.K.), Helmholtz Centre for Infection Research, Braunschweig, Germany; Georgetown University (J.F.K.), Washington, DC; Vascular Neurology and Stroke Unit (P.M.L.), Neurology Service, Department of Medicine, Clínica Alemana de Santiago, Universidad del Desarrollo and Department of Neurological Sciences, Universidad de Chile, Institute of Neurosurgery, Santiago; Neurodegenerative Diseases Unit (G.L.), Department of Basic Medicine, Neurosciences and Sense Organs, University Aldo Moro, Bari; Department of Clinical Research in Neurology presso Fondazione Card Panico (G.L.), Tricase (LE), University Aldo Moro, Bari, Italy; Institute of Epidemiology and Medical Biometry (G.N.), University of Ulm, Germany; Institute of Tropical Neurology (P.-M.P.), University of Limoges, France; and School of Public Health (L.W.S.), University of Alberta, Edmonton, Canada.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Suzanne Barker-Collo
From the Nuffield Department of Population Health (D.A.B.) and Stroke Prevention Research Unit (P.M.R.), University of Oxford; Department of Public Health and Primary Care (C.B.), University of Cambridge, UK; National Institute for Stroke and Applied Neurosciences (V.L.F.), AUT University, Auckland; Department of Psychology (S.B.-C.), University of Auckland, New Zealand; Department for Clinical Medicine and Preventive Medicine (M.B.), Danube-University, Krems, Austria; Faculty of Population Health Sciences (D.D.), University College London; Centre of Primary Care and Public Health (V.G.), Blizard Institute, Queen Mary, University of London, UK; Department of Clinical Neurosciences and Hotchkiss Brain Institute (N.J.), Department of Community Health Sciences and O'Brien Institute for Public Health, University of Calgary, Canada; Research Group Epidemiological and Statistical Methods (A.K.), Helmholtz Centre for Infection Research, Braunschweig, Germany; Georgetown University (J.F.K.), Washington, DC; Vascular Neurology and Stroke Unit (P.M.L.), Neurology Service, Department of Medicine, Clínica Alemana de Santiago, Universidad del Desarrollo and Department of Neurological Sciences, Universidad de Chile, Institute of Neurosurgery, Santiago; Neurodegenerative Diseases Unit (G.L.), Department of Basic Medicine, Neurosciences and Sense Organs, University Aldo Moro, Bari; Department of Clinical Research in Neurology presso Fondazione Card Panico (G.L.), Tricase (LE), University Aldo Moro, Bari, Italy; Institute of Epidemiology and Medical Biometry (G.N.), University of Ulm, Germany; Institute of Tropical Neurology (P.-M.P.), University of Limoges, France; and School of Public Health (L.W.S.), University of Alberta, Edmonton, Canada.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Michael Brainin
From the Nuffield Department of Population Health (D.A.B.) and Stroke Prevention Research Unit (P.M.R.), University of Oxford; Department of Public Health and Primary Care (C.B.), University of Cambridge, UK; National Institute for Stroke and Applied Neurosciences (V.L.F.), AUT University, Auckland; Department of Psychology (S.B.-C.), University of Auckland, New Zealand; Department for Clinical Medicine and Preventive Medicine (M.B.), Danube-University, Krems, Austria; Faculty of Population Health Sciences (D.D.), University College London; Centre of Primary Care and Public Health (V.G.), Blizard Institute, Queen Mary, University of London, UK; Department of Clinical Neurosciences and Hotchkiss Brain Institute (N.J.), Department of Community Health Sciences and O'Brien Institute for Public Health, University of Calgary, Canada; Research Group Epidemiological and Statistical Methods (A.K.), Helmholtz Centre for Infection Research, Braunschweig, Germany; Georgetown University (J.F.K.), Washington, DC; Vascular Neurology and Stroke Unit (P.M.L.), Neurology Service, Department of Medicine, Clínica Alemana de Santiago, Universidad del Desarrollo and Department of Neurological Sciences, Universidad de Chile, Institute of Neurosurgery, Santiago; Neurodegenerative Diseases Unit (G.L.), Department of Basic Medicine, Neurosciences and Sense Organs, University Aldo Moro, Bari; Department of Clinical Research in Neurology presso Fondazione Card Panico (G.L.), Tricase (LE), University Aldo Moro, Bari, Italy; Institute of Epidemiology and Medical Biometry (G.N.), University of Ulm, Germany; Institute of Tropical Neurology (P.-M.P.), University of Limoges, France; and School of Public Health (L.W.S.), University of Alberta, Edmonton, Canada.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Daniel Davis
From the Nuffield Department of Population Health (D.A.B.) and Stroke Prevention Research Unit (P.M.R.), University of Oxford; Department of Public Health and Primary Care (C.B.), University of Cambridge, UK; National Institute for Stroke and Applied Neurosciences (V.L.F.), AUT University, Auckland; Department of Psychology (S.B.-C.), University of Auckland, New Zealand; Department for Clinical Medicine and Preventive Medicine (M.B.), Danube-University, Krems, Austria; Faculty of Population Health Sciences (D.D.), University College London; Centre of Primary Care and Public Health (V.G.), Blizard Institute, Queen Mary, University of London, UK; Department of Clinical Neurosciences and Hotchkiss Brain Institute (N.J.), Department of Community Health Sciences and O'Brien Institute for Public Health, University of Calgary, Canada; Research Group Epidemiological and Statistical Methods (A.K.), Helmholtz Centre for Infection Research, Braunschweig, Germany; Georgetown University (J.F.K.), Washington, DC; Vascular Neurology and Stroke Unit (P.M.L.), Neurology Service, Department of Medicine, Clínica Alemana de Santiago, Universidad del Desarrollo and Department of Neurological Sciences, Universidad de Chile, Institute of Neurosurgery, Santiago; Neurodegenerative Diseases Unit (G.L.), Department of Basic Medicine, Neurosciences and Sense Organs, University Aldo Moro, Bari; Department of Clinical Research in Neurology presso Fondazione Card Panico (G.L.), Tricase (LE), University Aldo Moro, Bari, Italy; Institute of Epidemiology and Medical Biometry (G.N.), University of Ulm, Germany; Institute of Tropical Neurology (P.-M.P.), University of Limoges, France; and School of Public Health (L.W.S.), University of Alberta, Edmonton, Canada.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Valentina Gallo
From the Nuffield Department of Population Health (D.A.B.) and Stroke Prevention Research Unit (P.M.R.), University of Oxford; Department of Public Health and Primary Care (C.B.), University of Cambridge, UK; National Institute for Stroke and Applied Neurosciences (V.L.F.), AUT University, Auckland; Department of Psychology (S.B.-C.), University of Auckland, New Zealand; Department for Clinical Medicine and Preventive Medicine (M.B.), Danube-University, Krems, Austria; Faculty of Population Health Sciences (D.D.), University College London; Centre of Primary Care and Public Health (V.G.), Blizard Institute, Queen Mary, University of London, UK; Department of Clinical Neurosciences and Hotchkiss Brain Institute (N.J.), Department of Community Health Sciences and O'Brien Institute for Public Health, University of Calgary, Canada; Research Group Epidemiological and Statistical Methods (A.K.), Helmholtz Centre for Infection Research, Braunschweig, Germany; Georgetown University (J.F.K.), Washington, DC; Vascular Neurology and Stroke Unit (P.M.L.), Neurology Service, Department of Medicine, Clínica Alemana de Santiago, Universidad del Desarrollo and Department of Neurological Sciences, Universidad de Chile, Institute of Neurosurgery, Santiago; Neurodegenerative Diseases Unit (G.L.), Department of Basic Medicine, Neurosciences and Sense Organs, University Aldo Moro, Bari; Department of Clinical Research in Neurology presso Fondazione Card Panico (G.L.), Tricase (LE), University Aldo Moro, Bari, Italy; Institute of Epidemiology and Medical Biometry (G.N.), University of Ulm, Germany; Institute of Tropical Neurology (P.-M.P.), University of Limoges, France; and School of Public Health (L.W.S.), University of Alberta, Edmonton, Canada.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Nathalie Jetté
From the Nuffield Department of Population Health (D.A.B.) and Stroke Prevention Research Unit (P.M.R.), University of Oxford; Department of Public Health and Primary Care (C.B.), University of Cambridge, UK; National Institute for Stroke and Applied Neurosciences (V.L.F.), AUT University, Auckland; Department of Psychology (S.B.-C.), University of Auckland, New Zealand; Department for Clinical Medicine and Preventive Medicine (M.B.), Danube-University, Krems, Austria; Faculty of Population Health Sciences (D.D.), University College London; Centre of Primary Care and Public Health (V.G.), Blizard Institute, Queen Mary, University of London, UK; Department of Clinical Neurosciences and Hotchkiss Brain Institute (N.J.), Department of Community Health Sciences and O'Brien Institute for Public Health, University of Calgary, Canada; Research Group Epidemiological and Statistical Methods (A.K.), Helmholtz Centre for Infection Research, Braunschweig, Germany; Georgetown University (J.F.K.), Washington, DC; Vascular Neurology and Stroke Unit (P.M.L.), Neurology Service, Department of Medicine, Clínica Alemana de Santiago, Universidad del Desarrollo and Department of Neurological Sciences, Universidad de Chile, Institute of Neurosurgery, Santiago; Neurodegenerative Diseases Unit (G.L.), Department of Basic Medicine, Neurosciences and Sense Organs, University Aldo Moro, Bari; Department of Clinical Research in Neurology presso Fondazione Card Panico (G.L.), Tricase (LE), University Aldo Moro, Bari, Italy; Institute of Epidemiology and Medical Biometry (G.N.), University of Ulm, Germany; Institute of Tropical Neurology (P.-M.P.), University of Limoges, France; and School of Public Health (L.W.S.), University of Alberta, Edmonton, Canada.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
André Karch
From the Nuffield Department of Population Health (D.A.B.) and Stroke Prevention Research Unit (P.M.R.), University of Oxford; Department of Public Health and Primary Care (C.B.), University of Cambridge, UK; National Institute for Stroke and Applied Neurosciences (V.L.F.), AUT University, Auckland; Department of Psychology (S.B.-C.), University of Auckland, New Zealand; Department for Clinical Medicine and Preventive Medicine (M.B.), Danube-University, Krems, Austria; Faculty of Population Health Sciences (D.D.), University College London; Centre of Primary Care and Public Health (V.G.), Blizard Institute, Queen Mary, University of London, UK; Department of Clinical Neurosciences and Hotchkiss Brain Institute (N.J.), Department of Community Health Sciences and O'Brien Institute for Public Health, University of Calgary, Canada; Research Group Epidemiological and Statistical Methods (A.K.), Helmholtz Centre for Infection Research, Braunschweig, Germany; Georgetown University (J.F.K.), Washington, DC; Vascular Neurology and Stroke Unit (P.M.L.), Neurology Service, Department of Medicine, Clínica Alemana de Santiago, Universidad del Desarrollo and Department of Neurological Sciences, Universidad de Chile, Institute of Neurosurgery, Santiago; Neurodegenerative Diseases Unit (G.L.), Department of Basic Medicine, Neurosciences and Sense Organs, University Aldo Moro, Bari; Department of Clinical Research in Neurology presso Fondazione Card Panico (G.L.), Tricase (LE), University Aldo Moro, Bari, Italy; Institute of Epidemiology and Medical Biometry (G.N.), University of Ulm, Germany; Institute of Tropical Neurology (P.-M.P.), University of Limoges, France; and School of Public Health (L.W.S.), University of Alberta, Edmonton, Canada.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
John F. Kurtzke
From the Nuffield Department of Population Health (D.A.B.) and Stroke Prevention Research Unit (P.M.R.), University of Oxford; Department of Public Health and Primary Care (C.B.), University of Cambridge, UK; National Institute for Stroke and Applied Neurosciences (V.L.F.), AUT University, Auckland; Department of Psychology (S.B.-C.), University of Auckland, New Zealand; Department for Clinical Medicine and Preventive Medicine (M.B.), Danube-University, Krems, Austria; Faculty of Population Health Sciences (D.D.), University College London; Centre of Primary Care and Public Health (V.G.), Blizard Institute, Queen Mary, University of London, UK; Department of Clinical Neurosciences and Hotchkiss Brain Institute (N.J.), Department of Community Health Sciences and O'Brien Institute for Public Health, University of Calgary, Canada; Research Group Epidemiological and Statistical Methods (A.K.), Helmholtz Centre for Infection Research, Braunschweig, Germany; Georgetown University (J.F.K.), Washington, DC; Vascular Neurology and Stroke Unit (P.M.L.), Neurology Service, Department of Medicine, Clínica Alemana de Santiago, Universidad del Desarrollo and Department of Neurological Sciences, Universidad de Chile, Institute of Neurosurgery, Santiago; Neurodegenerative Diseases Unit (G.L.), Department of Basic Medicine, Neurosciences and Sense Organs, University Aldo Moro, Bari; Department of Clinical Research in Neurology presso Fondazione Card Panico (G.L.), Tricase (LE), University Aldo Moro, Bari, Italy; Institute of Epidemiology and Medical Biometry (G.N.), University of Ulm, Germany; Institute of Tropical Neurology (P.-M.P.), University of Limoges, France; and School of Public Health (L.W.S.), University of Alberta, Edmonton, Canada.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Pablo M. Lavados
From the Nuffield Department of Population Health (D.A.B.) and Stroke Prevention Research Unit (P.M.R.), University of Oxford; Department of Public Health and Primary Care (C.B.), University of Cambridge, UK; National Institute for Stroke and Applied Neurosciences (V.L.F.), AUT University, Auckland; Department of Psychology (S.B.-C.), University of Auckland, New Zealand; Department for Clinical Medicine and Preventive Medicine (M.B.), Danube-University, Krems, Austria; Faculty of Population Health Sciences (D.D.), University College London; Centre of Primary Care and Public Health (V.G.), Blizard Institute, Queen Mary, University of London, UK; Department of Clinical Neurosciences and Hotchkiss Brain Institute (N.J.), Department of Community Health Sciences and O'Brien Institute for Public Health, University of Calgary, Canada; Research Group Epidemiological and Statistical Methods (A.K.), Helmholtz Centre for Infection Research, Braunschweig, Germany; Georgetown University (J.F.K.), Washington, DC; Vascular Neurology and Stroke Unit (P.M.L.), Neurology Service, Department of Medicine, Clínica Alemana de Santiago, Universidad del Desarrollo and Department of Neurological Sciences, Universidad de Chile, Institute of Neurosurgery, Santiago; Neurodegenerative Diseases Unit (G.L.), Department of Basic Medicine, Neurosciences and Sense Organs, University Aldo Moro, Bari; Department of Clinical Research in Neurology presso Fondazione Card Panico (G.L.), Tricase (LE), University Aldo Moro, Bari, Italy; Institute of Epidemiology and Medical Biometry (G.N.), University of Ulm, Germany; Institute of Tropical Neurology (P.-M.P.), University of Limoges, France; and School of Public Health (L.W.S.), University of Alberta, Edmonton, Canada.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Giancarlo Logroscino
From the Nuffield Department of Population Health (D.A.B.) and Stroke Prevention Research Unit (P.M.R.), University of Oxford; Department of Public Health and Primary Care (C.B.), University of Cambridge, UK; National Institute for Stroke and Applied Neurosciences (V.L.F.), AUT University, Auckland; Department of Psychology (S.B.-C.), University of Auckland, New Zealand; Department for Clinical Medicine and Preventive Medicine (M.B.), Danube-University, Krems, Austria; Faculty of Population Health Sciences (D.D.), University College London; Centre of Primary Care and Public Health (V.G.), Blizard Institute, Queen Mary, University of London, UK; Department of Clinical Neurosciences and Hotchkiss Brain Institute (N.J.), Department of Community Health Sciences and O'Brien Institute for Public Health, University of Calgary, Canada; Research Group Epidemiological and Statistical Methods (A.K.), Helmholtz Centre for Infection Research, Braunschweig, Germany; Georgetown University (J.F.K.), Washington, DC; Vascular Neurology and Stroke Unit (P.M.L.), Neurology Service, Department of Medicine, Clínica Alemana de Santiago, Universidad del Desarrollo and Department of Neurological Sciences, Universidad de Chile, Institute of Neurosurgery, Santiago; Neurodegenerative Diseases Unit (G.L.), Department of Basic Medicine, Neurosciences and Sense Organs, University Aldo Moro, Bari; Department of Clinical Research in Neurology presso Fondazione Card Panico (G.L.), Tricase (LE), University Aldo Moro, Bari, Italy; Institute of Epidemiology and Medical Biometry (G.N.), University of Ulm, Germany; Institute of Tropical Neurology (P.-M.P.), University of Limoges, France; and School of Public Health (L.W.S.), University of Alberta, Edmonton, Canada.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Gabriele Nagel
From the Nuffield Department of Population Health (D.A.B.) and Stroke Prevention Research Unit (P.M.R.), University of Oxford; Department of Public Health and Primary Care (C.B.), University of Cambridge, UK; National Institute for Stroke and Applied Neurosciences (V.L.F.), AUT University, Auckland; Department of Psychology (S.B.-C.), University of Auckland, New Zealand; Department for Clinical Medicine and Preventive Medicine (M.B.), Danube-University, Krems, Austria; Faculty of Population Health Sciences (D.D.), University College London; Centre of Primary Care and Public Health (V.G.), Blizard Institute, Queen Mary, University of London, UK; Department of Clinical Neurosciences and Hotchkiss Brain Institute (N.J.), Department of Community Health Sciences and O'Brien Institute for Public Health, University of Calgary, Canada; Research Group Epidemiological and Statistical Methods (A.K.), Helmholtz Centre for Infection Research, Braunschweig, Germany; Georgetown University (J.F.K.), Washington, DC; Vascular Neurology and Stroke Unit (P.M.L.), Neurology Service, Department of Medicine, Clínica Alemana de Santiago, Universidad del Desarrollo and Department of Neurological Sciences, Universidad de Chile, Institute of Neurosurgery, Santiago; Neurodegenerative Diseases Unit (G.L.), Department of Basic Medicine, Neurosciences and Sense Organs, University Aldo Moro, Bari; Department of Clinical Research in Neurology presso Fondazione Card Panico (G.L.), Tricase (LE), University Aldo Moro, Bari, Italy; Institute of Epidemiology and Medical Biometry (G.N.), University of Ulm, Germany; Institute of Tropical Neurology (P.-M.P.), University of Limoges, France; and School of Public Health (L.W.S.), University of Alberta, Edmonton, Canada.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Pierre-Marie Preux
From the Nuffield Department of Population Health (D.A.B.) and Stroke Prevention Research Unit (P.M.R.), University of Oxford; Department of Public Health and Primary Care (C.B.), University of Cambridge, UK; National Institute for Stroke and Applied Neurosciences (V.L.F.), AUT University, Auckland; Department of Psychology (S.B.-C.), University of Auckland, New Zealand; Department for Clinical Medicine and Preventive Medicine (M.B.), Danube-University, Krems, Austria; Faculty of Population Health Sciences (D.D.), University College London; Centre of Primary Care and Public Health (V.G.), Blizard Institute, Queen Mary, University of London, UK; Department of Clinical Neurosciences and Hotchkiss Brain Institute (N.J.), Department of Community Health Sciences and O'Brien Institute for Public Health, University of Calgary, Canada; Research Group Epidemiological and Statistical Methods (A.K.), Helmholtz Centre for Infection Research, Braunschweig, Germany; Georgetown University (J.F.K.), Washington, DC; Vascular Neurology and Stroke Unit (P.M.L.), Neurology Service, Department of Medicine, Clínica Alemana de Santiago, Universidad del Desarrollo and Department of Neurological Sciences, Universidad de Chile, Institute of Neurosurgery, Santiago; Neurodegenerative Diseases Unit (G.L.), Department of Basic Medicine, Neurosciences and Sense Organs, University Aldo Moro, Bari; Department of Clinical Research in Neurology presso Fondazione Card Panico (G.L.), Tricase (LE), University Aldo Moro, Bari, Italy; Institute of Epidemiology and Medical Biometry (G.N.), University of Ulm, Germany; Institute of Tropical Neurology (P.-M.P.), University of Limoges, France; and School of Public Health (L.W.S.), University of Alberta, Edmonton, Canada.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Peter M. Rothwell
From the Nuffield Department of Population Health (D.A.B.) and Stroke Prevention Research Unit (P.M.R.), University of Oxford; Department of Public Health and Primary Care (C.B.), University of Cambridge, UK; National Institute for Stroke and Applied Neurosciences (V.L.F.), AUT University, Auckland; Department of Psychology (S.B.-C.), University of Auckland, New Zealand; Department for Clinical Medicine and Preventive Medicine (M.B.), Danube-University, Krems, Austria; Faculty of Population Health Sciences (D.D.), University College London; Centre of Primary Care and Public Health (V.G.), Blizard Institute, Queen Mary, University of London, UK; Department of Clinical Neurosciences and Hotchkiss Brain Institute (N.J.), Department of Community Health Sciences and O'Brien Institute for Public Health, University of Calgary, Canada; Research Group Epidemiological and Statistical Methods (A.K.), Helmholtz Centre for Infection Research, Braunschweig, Germany; Georgetown University (J.F.K.), Washington, DC; Vascular Neurology and Stroke Unit (P.M.L.), Neurology Service, Department of Medicine, Clínica Alemana de Santiago, Universidad del Desarrollo and Department of Neurological Sciences, Universidad de Chile, Institute of Neurosurgery, Santiago; Neurodegenerative Diseases Unit (G.L.), Department of Basic Medicine, Neurosciences and Sense Organs, University Aldo Moro, Bari; Department of Clinical Research in Neurology presso Fondazione Card Panico (G.L.), Tricase (LE), University Aldo Moro, Bari, Italy; Institute of Epidemiology and Medical Biometry (G.N.), University of Ulm, Germany; Institute of Tropical Neurology (P.-M.P.), University of Limoges, France; and School of Public Health (L.W.S.), University of Alberta, Edmonton, Canada.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Lawrence W. Svenson
From the Nuffield Department of Population Health (D.A.B.) and Stroke Prevention Research Unit (P.M.R.), University of Oxford; Department of Public Health and Primary Care (C.B.), University of Cambridge, UK; National Institute for Stroke and Applied Neurosciences (V.L.F.), AUT University, Auckland; Department of Psychology (S.B.-C.), University of Auckland, New Zealand; Department for Clinical Medicine and Preventive Medicine (M.B.), Danube-University, Krems, Austria; Faculty of Population Health Sciences (D.D.), University College London; Centre of Primary Care and Public Health (V.G.), Blizard Institute, Queen Mary, University of London, UK; Department of Clinical Neurosciences and Hotchkiss Brain Institute (N.J.), Department of Community Health Sciences and O'Brien Institute for Public Health, University of Calgary, Canada; Research Group Epidemiological and Statistical Methods (A.K.), Helmholtz Centre for Infection Research, Braunschweig, Germany; Georgetown University (J.F.K.), Washington, DC; Vascular Neurology and Stroke Unit (P.M.L.), Neurology Service, Department of Medicine, Clínica Alemana de Santiago, Universidad del Desarrollo and Department of Neurological Sciences, Universidad de Chile, Institute of Neurosurgery, Santiago; Neurodegenerative Diseases Unit (G.L.), Department of Basic Medicine, Neurosciences and Sense Organs, University Aldo Moro, Bari; Department of Clinical Research in Neurology presso Fondazione Card Panico (G.L.), Tricase (LE), University Aldo Moro, Bari, Italy; Institute of Epidemiology and Medical Biometry (G.N.), University of Ulm, Germany; Institute of Tropical Neurology (P.-M.P.), University of Limoges, France; and School of Public Health (L.W.S.), University of Alberta, Edmonton, Canada.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Full PDF
Citation
Development of the Standards of Reporting of Neurological Disorders (STROND) checklist
A guideline for the reporting of incidence and prevalence studies in neuroepidemiology
Derrick A. Bennett, Carol Brayne, Valery L. Feigin, Suzanne Barker-Collo, Michael Brainin, Daniel Davis, Valentina Gallo, Nathalie Jetté, André Karch, John F. Kurtzke, Pablo M. Lavados, Giancarlo Logroscino, Gabriele Nagel, Pierre-Marie Preux, Peter M. Rothwell, Lawrence W. Svenson
Neurology Sep 2015, 85 (9) 821-828; DOI: 10.1212/WNL.0000000000001866

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Permissions

Make Comment

See Comments

Downloads
2112

Share

  • Article
  • Figures & Data
  • Info & Disclosures
Loading

Abstract

Background: Incidence and prevalence studies of neurologic disorders play an important role in assessing the burden of disease and planning services. However, the assessment of disease estimates is hindered by problems in reporting for such studies. Despite a growth in published reports, existing guidelines relate to analytical rather than descriptive epidemiologic studies. There are also no user-friendly tools (e.g., checklists) available for authors, editors, and peer reviewers to facilitate best practice in reporting of descriptive epidemiologic studies for most neurologic disorders.

Objective: The Standards of Reporting of Neurological Disorders (STROND) is a guideline that consists of recommendations and a checklist to facilitate better reporting of published incidence and prevalence studies of neurologic disorders.

Methods: A review of previously developed guidance was used to produce a list of items required for incidence and prevalence studies in neurology. A 3-round Delphi technique was used to identify the “basic minimum items” important for reporting, as well as some additional “ideal reporting items.” An e-consultation process was then used in order to gauge opinion by external neuroepidemiologic experts on the appropriateness of the items included in the checklist.

Findings: Of 38 candidate items, 15 items and accompanying recommendations were developed along with a user-friendly checklist.

Conclusions: The introduction and use of the STROND checklist should lead to more consistent, transparent, and contextualized reporting of descriptive neuroepidemiologic studies resulting in more applicable and comparable findings and ultimately support better health care decisions.

GLOSSARY

GBD=
Global Burden of Disease and Injuries;
HIC=
high-income countries;
LMIC=
low- to middle-income countries;
PD=
Parkinson disease;
STROBE=
Strengthening the Reporting of Observational Studies in Epidemiology;
STROND=
Standards of Reporting of Neurological Disorders

Footnotes

  • ↵* These authors are listed in alphabetical order.

  • Editor's Note: This article was published on June 19, 2015, in the European Journal of Epidemiology and is republished in Neurology with permission. The article was not peer-reviewed by Neurology, and authors' potential conflicts of interest are not disclosed.

  • Go to Neurology.org for full disclosures. Funding information and disclosures deemed relevant by the authors, if any, are provided at the end of the article.

  • Supplemental data at Neurology.org

  • Received June 6, 2015.
  • Accepted in final form June 10, 2015.
  • © 2015 American Academy of Neurology
View Full Text

Disputes & Debates: Rapid online correspondence

No comments have been published for this article.
Comment

REQUIREMENTS

If you are uploading a letter concerning an article:
You must have updated your disclosures within six months: http://submit.neurology.org

Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.

If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.

Submission specifications:

  • Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
  • Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
  • Submit only on articles published within 6 months of issue date.
  • Do not be redundant. Read any comments already posted on the article prior to submission.
  • Submitted comments are subject to editing and editor review prior to posting.

More guidelines and information on Disputes & Debates

Compose Comment

More information about text formats

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
NOTE: The first author must also be the corresponding author of the comment.
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g. higgs-boson@gmail.com
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Publishing Agreement
NOTE: All authors, besides the first/corresponding author, must complete a separate Publishing Agreement Form and provide via email to the editorial office before comments can be posted.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Vertical Tabs

You May Also be Interested in

Back to top
  • Article
    • Abstract
    • GLOSSARY
    • METHODS
    • RESULTS
    • DISCUSSION
    • Appendix
    • Footnotes
    • REFERENCES
  • Figures & Data
  • Info & Disclosures
Advertisement

Topics Discussed

  • All Clinical Neurology
  • Prevalence studies
  • Incidence studies
  • Other Education

Alert Me

  • Alert me when eletters are published
Neurology: 99 (6)

Articles

  • Ahead of Print
  • Current Issue
  • Past Issues
  • Popular Articles
  • Translations

About

  • About the Journals
  • Ethics Policies
  • Editors & Editorial Board
  • Contact Us
  • Advertise

Submit

  • Author Center
  • Submit a Manuscript
  • Information for Reviewers
  • AAN Guidelines
  • Permissions

Subscribers

  • Subscribe
  • Activate a Subscription
  • Sign up for eAlerts
  • RSS Feed
Site Logo
  • Visit neurology Template on Facebook
  • Follow neurology Template on Twitter
  • Visit Neurology on YouTube
  • Neurology
  • Neurology: Clinical Practice
  • Neurology: Genetics
  • Neurology: Neuroimmunology & Neuroinflammation
  • Neurology: Education
  • AAN.com
  • AANnews
  • Continuum
  • Brain & Life
  • Neurology Today

Wolters Kluwer Logo

Neurology | Print ISSN:0028-3878
Online ISSN:1526-632X

© 2022 American Academy of Neurology

  • Privacy Policy
  • Feedback
  • Advertise